Hostname: page-component-8448b6f56d-m8qmq Total loading time: 0 Render date: 2024-04-15T18:44:22.215Z Has data issue: false hasContentIssue false
  • English
  • Français

Brain Neurotransmitter Receptors in Friedreich's Ataxia

Published online by Cambridge University Press:  18 September 2015

I. D. Reisine ,
J. Azari ,
P.C. Johnson ,
A. Barbeau ,
R. Huxtable  and
H.I. Yamamura
I. D. Reisine
Affiliation:
Departments of Pharmacology and Pathology, College of Medicine, University of Arizona Health Sciences Center, Tucson and the Department of Neurobiology, Clinical Research Institute of Montreal
J. Azari
Affiliation:
Departments of Pharmacology and Pathology, College of Medicine, University of Arizona Health Sciences Center, Tucson and the Department of Neurobiology, Clinical Research Institute of Montreal
P.C. Johnson
Affiliation:
Departments of Pharmacology and Pathology, College of Medicine, University of Arizona Health Sciences Center, Tucson and the Department of Neurobiology, Clinical Research Institute of Montreal
A. Barbeau
Affiliation:
Departments of Pharmacology and Pathology, College of Medicine, University of Arizona Health Sciences Center, Tucson and the Department of Neurobiology, Clinical Research Institute of Montreal
R. Huxtable
Affiliation:
Departments of Pharmacology and Pathology, College of Medicine, University of Arizona Health Sciences Center, Tucson and the Department of Neurobiology, Clinical Research Institute of Montreal
H.I. Yamamura
Affiliation:
Departments of Pharmacology and Pathology, College of Medicine, University of Arizona Health Sciences Center, Tucson and the Department of Neurobiology, Clinical Research Institute of Montreal
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The binding of ‘H-quinu-clidinyl henzilate. a muscarinic cholinergic antagonist, of xH-dihydroalprenolol, a beta adrenergic antagonist, and of ﹜H-flunitrazepam, a ligand which labels benzodiazepine receptors, was examined in several regions of control and Fried-retch's ataxia (FA) brains. yH-Quinuclidi-nyl henzilate binding appeared to increase in the inferior olivory nucleus, anterior and posterior cerebellar vermi but was unaltered m the dentate nucleus and cerebellar hemisphere of FA brain. The binding of 1 H-dihydroalprenolol seemed to increase in the inferior olivary nucleus yet was not different from controls in the dentate nucleus, cerebellar hemisphere, anterior and posterior cerebellar vermi of FA brains. * H-Flunitrazepam binding was slightly lowered in the inferior olivary and dentate nuclei but was unchanged in the other FA brain regions examined. The present study suggests possible trends in neurotransmitter receptor alterations in post-mortem brain tissue of FA patients.

Type
Research Article
Information
Canadian Journal of Neurological Sciences , Volume 6 , Issue 2 , May 1979 , pp. 259 - 262
Copyright
Copyright © Canadian Neurological Sciences Federation 1979

References

Bylund, D. B. and Snyder, S. H. (1976). Beta adrenergic receptor binding in membrane preparations from mammalian brain. Mol. Pharm., 12, 568–580.Google ScholarPubMed
Friedreich, N. (1861). Ueber degenerative atrophie der spinalen hinterstrange. Congress Sitzungsbericht der Deutschen Aerzte and Naturforscher, Speier.Google Scholar
Huxtable, R., Azari, J., Reisine, T. D., Johnson, P. C., Yamamura, H. I. and Barbeau, A. (1978). Regional distribution of amino acids in Friedreich's ataxia brains. The Can. J. Neurol. Sci., this issue.Google Scholar
Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265–275.CrossRefGoogle ScholarPubMed
Noback, C. R. and Demarest, R. J. (1972). The Nervous System: Introduction and Review, McGraw-Hill, Inc., New York, pp. 121–131.Google Scholar
Reisine, T. D., Fields, J. Z., Yamamura, H. I., Bird, E. D., Spokes, E.Schreiner, P., and Enna, S. J. (1977). Neurotransmitter receptor alterations in Parkinson's disease. Life Sci., 21, 335–334.Google ScholarPubMed
Speth, R. C., Wastek, G. J., Johnson, P. C. and Yamamura, H. I. (1978). Benzodiazepine binding in human brain: Characterization using 3H-flunitrazepam life Sci. 22, 859–866.Google Scholar
Wintrobe, M. M., Thorn, G. W., Adams, R. D., Braunwald, E., Isselbacher, K. J. and Peterdorf, R. G. (eds.) 1974. Harrison's Principles of Internal Medicine. McGraw-Hill Book comp., New York, pp. 1740–1741.Google Scholar
Yamamura, H. I. and Snyder, S. H. (1974). Muscarinic cholinergic binding in rat brain. Proc. Nat. Acad. Sci., 71, 1725–1729.Google ScholarPubMed
Yamamura, H. I. (1978). Neurotransmitter receptor alterations in Huntingtons disease. In T. Melnechuk's (ed.). Cell Receptor Disorders, Western Behavioral Sciences Institute, La Jolla pp. 97–106.Google Scholar